LumiraDx is a healthcare company that manufactures a diagnostic platform to support a menu of tests with lab comparable performance.
LumiraDx's investors include Bill & Melinda Gates Foundation, Morningside, UBS O'Connor, Bantam Group, Ron Zwanziger.
LumiraDx is headquartered in London, United Kingdom.
LumiraDx is a healthcare company that manufactures a diagnostic platform to support a menu of tests with lab comparable performance.
LumiraDx is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"LumiraDx — Funding & Investors." VCBacked, February 14, 2023, https://www.vcbacked.co/company/lumiradx. Accessed August 14, 2026.
VCBacked. (2023). LumiraDx — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/lumiradx
{{cite web |title=LumiraDx — Funding & Investors |url=https://www.vcbacked.co/company/lumiradx |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated